Robotic ureteric reimplantation for benign disease in a tertiary UK centre: safe and effective
World Journal of Urology · 11.04.2026 · 44 (1)
DOI: 10.1007/s00345-026-06375-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Urology, online erschienen am 11.04.2026. Verfasst von Samuel Stephen Folkard und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guy's Urology, Great Maze Pond, London, United Kingdom. samuel.folkard@nhs.net. Hauptthemen laut MEDLINE: Ureter, Robotic Surgical Procedures, Replantation, Ureteral Diseases. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: Robotic ureteric reimplantation is increasingly utilised for benign distal and mid-ureteric pathology. However, medium-term outcomes remain underreported, particularly in UK practice, and optimal follow-up uncertain. We aimed to evaluate the safety and efficacy of robotic ureteric reimplantation for benign indications and inform optimal follow-up strategies. METHODS: Retrospective review of 67 patients undergoing robotic ureteric reimplantation at a tertiary UK centre between 2016 and 2023. Primary outcomes included postoperative obstruction and need for long-term urinary drainage. Secondary outcomes were post-operative complications, change in renal function, and hospital stay. Descriptive statistics and paired t-tests were used. KEY FINDINGS AND LIMITATIONS: Sixty-seven patients (40 females, 27 males) underwent robotic ureteric reimplantation for benign disease. Causes were urological (54%) and gynaecological (45%), mostly operative injuries. Techniques included Lich-Gregoir (n = 56), psoas hitch (n = 5), and Boari flap (n = 6). One case was converted to open surgery at the start of the learning curve. Median hospital stay was 2 days. Mean follow-up was 709 days. Four patients (6%) showed radiological obstruction; three required further intervention. Renal function remained stable (mean creatinine change − 2 ± 12.5 mmol/L, p = 0.07). Eleven patients experienced Clavien-Dindo grade II complications. One patient with prior radiotherapy required cystectomy for a poorly compliant bladder. CONCLUSIONS AND CLINICAL IMPLICATIONS: Robotic ureteric reimplantation for benign disease is safe and effective. Most complications occur within the first year, and long-term monitoring is recommended in select cases including radiation cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guy's Urology, Great Maze Pond, London, United Kingdom. samuel.folkard@nhs.net.
- King's College London, London, United Kingdom. samuel.folkard@nhs.net.
- Guy's Urology, Great Maze Pond, London, United Kingdom.
- King's College London, London, United Kingdom.
Zitieren
APA
Folkard, S. S., Spazzapan, M., Gad, M., Sharples, H., Chapman, L., Clark, C., Khan, S., Nair, R., Malde, S., & Sahai, A. (2026). Robotic ureteric reimplantation for benign disease in a tertiary UK centre: safe and effective. World Journal of Urology, 44(1). https://doi.org/10.1007/s00345-026-06375-4
Vancouver
Folkard SS, Spazzapan M, Gad M, Sharples H, Chapman L, Clark C, et al. Robotic ureteric reimplantation for benign disease in a tertiary UK centre: safe and effective. World Journal of Urology. 2026;44(1). doi:10.1007/s00345-026-06375-4
BibTeX
@article{Folkard2026,
author = {Folkard, Samuel Stephen and Spazzapan, Martina and Gad, Mohamed and Sharples, Harry and Chapman, Lucy and Clark, Calum and Khan, Shamim and Nair, Raj and Malde, Sachin and Sahai, Arun},
title = {Robotic ureteric reimplantation for benign disease in a tertiary UK centre: safe and effective},
journal = {World Journal of Urology},
year = {2026},
volume = {44},
number = {1},
doi = {10.1007/s00345-026-06375-4}
}
EUVIMED